Congressman Mike Turner and Congressman Jim Sensenbrenner (WI-05) hosted a Heroin Epidemic Response Roundtable. Congressman Turner released the following statement:
“The opioid epidemic is a national crisis and is taking a toll on our communities. Ohio continues to work on innovative solutions and programs to help end the scourge of heroin and opioid addiction in our community. I thank Congressman Sensenbrenner for his leadership and for joining me today for this important discussion.”
Congressman Sensenbrenner released the following statement:
“Opioid and heroin abuse is an issue that doesn’t discriminate – it hurts individuals, families, and communities in every corner of this country. I’m happy to be in Dayton today with Congressman Turner to discuss solutions to this serious issue and offer hope to all those impacted by this devastating epidemic.”
Congressman Turner has been fighting the opioid epidemic in Dayton since 2013:
- December 18, 2013: Toured Soin Medical Center, where issue of Heroin-Exposed Newborns was raised.
- March 10, 2014: Met with area hospitals to discuss the growing issue of Heroin-Exposed Newborns.
- May 15, 2014: Visited Dayton Children’s Hospital NICU to discuss infant heroin exposure and the withdrawal and recovery process.
- June 30, 2014: Held a Community Forum on the Effects of the Heroin Epidemic on Newborns.
- August 27, 2014: Visited the Women’s Recovery Center.
- May 2015: Held Community Summit on Heroin-Exposed Infants.
- August 21, 2015: Toured Greene County Jail and Green Leaf Alcohol and Drug Treatment Program; met with criminal justice system administrators and substance abuse and mental health leadership.
- November 18, 2015: Met with ONDCP Director Michael Botticelli and introduced the TREAT Act with Congresswoman Marcia L. Fudge (OH-11) and Congresswoman Niki Tsongas (MA-3).
- May 12, 2016: The House passed an amendment he cosponsored to increase access to treatment for pregnant women struggling with substance abuse.
- May 25, 2016: Introduced CRIB Act to help expand access to specialized treatment and recovery options for infants suffering from neonatal abstinence syndrome (NAS), a withdrawal condition in newborns often caused by use of opioids and other addictive substances in pregnant women.